Standard BioTools Inc. (LAB)
USD 1.99
(-10.18%)
USD 1.99
(-10.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -54.45 Million USD | 57.83% |
| 2022 | -173.57 Million USD | -156.43% |
| 2021 | -43.76 Million USD | -27.89% |
| 2020 | -34.6 Million USD | -0.01% |
| 2019 | -46.62 Million USD | -11.78% |
| 2018 | -31.02 Million USD | 21.37% |
| 2017 | -39.67 Million USD | 30.23% |
| 2016 | -56.41 Million USD | -43.99% |
| 2015 | -32.86 Million USD | -3.29% |
| 2014 | -38.5 Million USD | -178.33% |
| 2013 | -13.82 Million USD | 18.76% |
| 2012 | -16.77 Million USD | -15.68% |
| 2011 | -18.14 Million USD | -11.04% |
| 2010 | -13.52 Million USD | 18.67% |
| 2009 | -14.67 Million USD | 40.1% |
| 2008 | -26.11 Million USD | -32.41% |
| 2007 | -20.91 Million USD | -3.1% |
| 2006 | -19.83 Million USD | 0.0% |
| 2001 | -67.45 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -31.71 Million USD | 44.44% |
| 2024 Q1 | -33.54 Million USD | -145.06% |
| 2024 Q2 | -38.13 Million USD | -14.24% |
| 2023 Q2 | -9.71 Million USD | 17.66% |
| 2023 Q1 | -11.8 Million USD | 26.09% |
| 2023 FY | - USD | 57.83% |
| 2023 Q4 | -11 Million USD | 31.51% |
| 2023 Q3 | -16.06 Million USD | -65.28% |
| 2022 Q4 | -15.96 Million USD | 37.36% |
| 2022 Q2 | -37.96 Million USD | -62.15% |
| 2022 FY | - USD | -156.43% |
| 2022 Q3 | -25.48 Million USD | 32.87% |
| 2022 Q1 | -23.41 Million USD | -155.3% |
| 2021 FY | - USD | -27.89% |
| 2021 Q1 | -15.68 Million USD | -29.2% |
| 2021 Q2 | -16.76 Million USD | -6.86% |
| 2021 Q3 | -10.42 Million USD | 37.81% |
| 2021 Q4 | -9.17 Million USD | 12.03% |
| 2020 Q4 | -12.14 Million USD | -772.27% |
| 2020 Q1 | -11.7 Million USD | -146.47% |
| 2020 FY | - USD | -0.01% |
| 2020 Q2 | -9.37 Million USD | 19.91% |
| 2020 Q3 | -1.39 Million USD | 85.15% |
| 2019 Q2 | -10.44 Million USD | -7.34% |
| 2019 FY | - USD | -11.78% |
| 2019 Q1 | -9.73 Million USD | -41.09% |
| 2019 Q3 | -9.67 Million USD | 7.34% |
| 2019 Q4 | -4.74 Million USD | 50.95% |
| 2018 Q1 | -7.75 Million USD | -71.22% |
| 2018 FY | - USD | 21.37% |
| 2018 Q2 | -5.69 Million USD | 26.57% |
| 2018 Q3 | -10.6 Million USD | -86.12% |
| 2018 Q4 | -6.89 Million USD | 34.95% |
| 2017 FY | - USD | 30.23% |
| 2017 Q4 | -4.53 Million USD | 57.62% |
| 2017 Q3 | -10.69 Million USD | 5.95% |
| 2017 Q2 | -11.36 Million USD | 11.03% |
| 2017 Q1 | -12.77 Million USD | 7.23% |
| 2016 FY | - USD | -43.99% |
| 2016 Q1 | -14.82 Million USD | -44.31% |
| 2016 Q2 | -13.7 Million USD | 7.57% |
| 2016 Q3 | -14.11 Million USD | -3.0% |
| 2016 Q4 | -13.77 Million USD | 2.45% |
| 2015 Q4 | -10.27 Million USD | -26.62% |
| 2015 Q1 | -10.98 Million USD | -18.83% |
| 2015 Q2 | -9.81 Million USD | 10.68% |
| 2015 Q3 | -8.11 Million USD | 17.28% |
| 2015 FY | - USD | -3.29% |
| 2014 Q4 | -9.24 Million USD | 24.88% |
| 2014 FY | - USD | -178.33% |
| 2014 Q3 | -12.3 Million USD | -7.6% |
| 2014 Q2 | -11.43 Million USD | -130.94% |
| 2014 Q1 | -4.95 Million USD | -69.13% |
| 2013 FY | - USD | 18.76% |
| 2013 Q4 | -2.92 Million USD | -13.23% |
| 2013 Q3 | -2.58 Million USD | 24.39% |
| 2013 Q2 | -3.42 Million USD | 27.17% |
| 2013 Q1 | -4.69 Million USD | -50.46% |
| 2012 Q4 | -3.12 Million USD | 12.06% |
| 2012 Q2 | -4.02 Million USD | 32.31% |
| 2012 Q3 | -3.54 Million USD | 11.91% |
| 2012 Q1 | -5.95 Million USD | -110.54% |
| 2012 FY | - USD | -15.68% |
| 2011 FY | - USD | -11.04% |
| 2011 Q3 | -3.64 Million USD | -4.26% |
| 2011 Q1 | -5.24 Million USD | -214.25% |
| 2011 Q4 | -2.82 Million USD | 22.51% |
| 2011 Q2 | -3.49 Million USD | 33.33% |
| 2010 Q4 | -1.67 Million USD | 34.94% |
| 2010 Q3 | -2.56 Million USD | 35.81% |
| 2010 Q2 | -3.99 Million USD | 12.23% |
| 2010 Q1 | -4.55 Million USD | -35.92% |
| 2010 FY | - USD | 18.67% |
| 2009 Q4 | -3.35 Million USD | 0.0% |
| 2009 FY | - USD | 40.1% |
| 2008 FY | - USD | -32.41% |
| 2007 FY | - USD | -3.1% |
| 2006 FY | - USD | 0.0% |
| 2001 Q3 | -19.61 Million USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | -11.25 Million USD | 42.59% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 74.506% |
| Prenetics Global Limited | -47.89 Million USD | -13.698% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -3128.038% |
| CareDx, Inc | -89.65 Million USD | 39.261% |
| Exact Sciences Corporation | 41.87 Million USD | 230.043% |
| Exagen Inc. | -19.15 Million USD | -184.326% |
| Inotiv, Inc. | -26.5 Million USD | -105.452% |
| Guardant Health, Inc. | -433.3 Million USD | 87.432% |
| Biodesix, Inc. | -37.1 Million USD | -46.772% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -2091.287% |
| Precipio, Inc. | -4.31 Million USD | -1161.163% |
| iSpecimen Inc. | -9.1 Million USD | -498.184% |
| Natera, Inc. | -383.27 Million USD | 85.792% |
| Aspira Women's Health Inc. | -16.49 Million USD | -230.223% |
| 23andMe Holding Co. | -291.87 Million USD | 81.342% |
| Castle Biosciences, Inc. | -45.02 Million USD | -20.951% |
| Personalis, Inc. | -96.8 Million USD | 43.747% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 53.679% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -467.79% |
| OpGen, Inc. | -29.51 Million USD | -84.531% |
| T2 Biosystems, Inc. | -43.87 Million USD | -24.119% |
| Myriad Genetics, Inc. | -67.8 Million USD | 19.68% |
| ICON Public Limited Company | 1.63 Billion USD | 103.338% |
| NeoGenomics, Inc. | -17.6 Million USD | -209.292% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -3128.038% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 104.472% |
| RadNet, Inc. | 292.78 Million USD | 118.6% |
| MDxHealth SA | -30.46 Million USD | -78.735% |
| Psychemedics Corporation | -251 Thousand USD | -21596.016% |
| Illumina, Inc. | -608 Million USD | 91.043% |
| Check-Cap Ltd. | -17.64 Million USD | -208.556% |
| Twist Bioscience Corporation | -176.7 Million USD | 69.182% |
| DarioHealth Corp. | -53.49 Million USD | -1.8% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -16.981% |
| Sera Prognostics, Inc. | -35.28 Million USD | -54.326% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -456.547% |
| OPKO Health, Inc. | -65.51 Million USD | 16.88% |
| Medpace Holdings, Inc. | 363.15 Million USD | 114.996% |
| Neogen Corporation | 182.59 Million USD | 129.824% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -518.078% |
| Prenetics Global Limited | -47.89 Million USD | -13.698% |
| Mainz Biomed B.V. | -25.01 Million USD | -117.73% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -613.787% |
| Trinity Biotech plc | -24.09 Million USD | -125.981% |
| Neuronetics, Inc. | -22.75 Million USD | -139.277% |
| Sotera Health Company | 514.14 Million USD | 110.592% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -613.787% |